about
Clinical use of pasireotide for Cushing's disease in adultsThe risks of overlooking the diagnosis of secreting pituitary adenomasUpdate on medical treatment for Cushing's disease.Long-term treatment of Cushing's disease with pasireotide: 5-year results from an open-label extension study of a Phase III trialRecurrent gain-of-function USP8 mutations in Cushing's disease.Cushing Disease After Treatment of Nonfunctional Pituitary Adenoma: A Case Report and Literature Review.Up-to 5-year efficacy of pasireotide in a patient with Cushing's disease and pre-existing diabetes: literature review and clinical practice considerations.Medical combination therapies in Cushing's disease.Incremental healthcare resource utilization and costs in US patients with Cushing's disease compared with diabetes mellitus and population controls.Incidence of Cushing's syndrome and Cushing's disease in commercially-insured patients <65 years old in the United States.Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly.Pituitary magnetic resonance imaging in Cushing's disease.Effects of adrenolytic mitotane on drug elimination pathways assessed in vitro.Diabetes in Cushing Disease.Clinical management of critically ill patients with Cushing's disease due to ACTH-secreting pituitary macroadenomas: effectiveness of presurgical treatment with pasireotide.The role of an acute pasireotide suppression test in predicting response to treatment in patients with Cushing's disease: findings from a pilot study.Treatment patterns in Cushing's disease patients in two large United States nationwide databases: application of a novel, graphical methodology.Follow-up intervals in patients with Cushing's disease: recommendations from a panel of experienced pituitary clinicians.Roles of Hippocampal Somatostatin Receptor Subtypes in Stress Response and Emotionality.Effects of pasireotide (SOM230) on protein turnover and p70S6 kinase-S6 ribosomal protein signaling pathway in rat skeletal muscle cells.Pituitary-Targeted Dynamic Contrast-Enhanced Multisection CT for Detecting MR Imaging-Occult Functional Pituitary Microadenoma.ATR-101, a selective ACAT1 inhibitor, decreases ACTH-stimulated cortisol concentrations in dogs with naturally occurring Cushing's syndrome.Identification of recurrent USP48 and BRAF mutations in Cushing's disease
P2860
Q26858933-6D602BA6-5927-493D-AF9A-5DEC99D67305Q28076665-19432AF8-E42E-4532-BB3E-E713963FAA28Q33802284-96EF1473-EC96-47BE-B570-8FA19D90F0AFQ33840655-D039AFB3-9A6D-4769-9561-88D4722487FBQ35146226-7F8C1AB4-4D9F-4233-856F-7836E83793CFQ36420964-6746217E-4021-465B-97E3-CE83EA3116C9Q38222170-D0A5A14F-7B57-47FC-82F7-548844FE3631Q38342520-20CA06DB-1511-4888-B9B2-0F404ACDAA8DQ38405559-400142D9-D9B0-4A3E-93BD-66FF82D37636Q38420825-317B8036-F9A3-4EDE-A290-8FB228C461F3Q38683309-B1BF0C55-CA12-4F61-B06A-837F89F3C1A4Q38902459-285933E7-AC55-4481-9385-C2D61C48228FQ38925278-A138A701-9CE4-4AF9-87F4-0999645767FFQ39212408-68D5346B-1263-40F8-88D6-51F10FA7CF91Q41069104-AE8DC6F0-93F2-4DF7-B4D5-0046E024956DQ41698329-C158B883-29E5-4250-9AAE-BAF19997C51DQ43656346-548301FB-D84D-4A1D-8ABA-B8A5F43920B6Q46644513-C9030F80-059A-42DD-BD91-23F63528C177Q48392547-7293DD4C-9C26-4810-B387-8C184F8E5EF5Q51170240-6F3110D4-7654-405C-8606-5692F7F22532Q53030549-C8A5B232-16FB-4475-B579-F9D0A9E4D6B9Q55316663-26A50A06-C58B-4334-A6E5-1B3F58CEEE9FQ58793747-AEC31590-9CC2-4533-A61D-3654E244958B
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Managing Cushing's disease: the state of the art.
@en
type
label
Managing Cushing's disease: the state of the art.
@en
prefLabel
Managing Cushing's disease: the state of the art.
@en
P2860
P1433
P1476
Managing Cushing's disease: the state of the art.
@en
P2093
Annamaria Colao
Felipe F Casanueva
P2860
P2888
P356
10.1007/S12020-013-0129-2
P577
2014-01-11T00:00:00Z